Keyword: Dietmar Hopp


Mooted US Vaccine “Poaching” Raises German Ire

17.03.2020 - News reports that the US government had offered considerable sums of money to lure top-level scientists working for a Germany-based privately owned biotech, or even the company...


German Biotech Investor Bets $105 Million More on CureVac

18.09.2012 - Billionaire German investor Dietmar Hopp is betting another €80 million ($105 million) on CureVac, a pioneer of vaccines based on a molecule related to DNA, in one of the biggest...